Deborah van de Wal, MD

PhD candidate
Netherlands Cancer Institute/ Antoni van Leeuwenhoek
Amsterdam, Noord-Holland, Netherlands

My name is Deborah, I am a PhD student at the NKI in the Netherlands. My PhD focusses on health-related quality of life of GIST patients, specifically advanced and metastatic GIST patients responding to long-term tyrosine kinase inhibitor (TKI) treatment. After I finished my medical school and before I started my PhD, I worked in several hospitals as resident not in training, but I hope to become an oncologist one day.

Disclosure information not submitted.

Presentation(s):

• Paper 04 - THE PATIENT-REPORTED OUTCOMES (PROS) IN SARCOMA INITIATIVE: TOWARDS A GLOBAL COLLABORATIVE MEASUREMENT STRATEGY

  Thursday, November 2, 2023
  9:00 AM – 10:00 AM  

• Paper 87 - SEVERE FEAR OF RECURRENCE OR PROGRESSION, SYMPTOMS OF ANXIETY AND DEPRESSION IN GASTROINTESTINAL STROMAL TUMOR (GIST) PATIENTS IN THE NETHERLANDS: DATA FROM A CROSS-SECTIONAL MULTICENTER STUDY

  Saturday, November 4, 2023
  3:00 PM – 4:00 PM